{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:55:36Z","timestamp":1790391336382,"version":"4.1.0"},"reference-count":61,"publisher":"Siapec Servizi Srl","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-231","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T18:38:13Z","timestamp":1613673493000},"page":"28-38","source":"Crossref","is-referenced-by-count":37,"title":["Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach"],"prefix":"10.32074","volume":"113","author":[{"given":"Claudio","family":"Luchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mattiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Marchiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Maragliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2021,2]]},"reference":[{"key":"10.32074\/1591-951X-231_ref1","doi-asserted-by":"crossref","unstructured":"Ayabe RI, Wach M, Ruff S, et al. Primary Gallbladder Neuroendocrine Tumors: Insights into a Rare Histology Using a Large National Database. Ann Surg Oncol 2019;26:3577-85. https:\/\/doi.org\/10.1245\/s10434-019-07440-6.","DOI":"10.1245\/s10434-019-07440-6"},{"key":"10.32074\/1591-951X-231_ref2","doi-asserted-by":"crossref","unstructured":"Michalopoulos N, Papavramidis TS, Karayannopoulou G, et al Neuroendocrine tumors of extrahepatic biliary tract. Pathol Oncol Res 2014;20:765-75. https:\/\/doi.org\/10.1007\/s12253-014-9808-4","DOI":"10.1007\/s12253-014-9808-4"},{"key":"10.32074\/1591-951X-231_ref3","doi-asserted-by":"crossref","unstructured":"Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg 2005;29:92101. https:\/\/doi.org\/10.1007\/s00268-004-7443-z","DOI":"10.1007\/s00268-004-7443-z"},{"key":"10.32074\/1591-951X-231_ref4","doi-asserted-by":"crossref","unstructured":"Niu C, Wang S, Guan Q, et al. Neuroendocrine tumors of the gallbladder. Oncol Lett 2020;19:3381-8. https:\/\/doi.org\/10.3892\/ol.2020.11461","DOI":"10.3892\/ol.2020.11461"},{"key":"10.32074\/1591-951X-231_ref5","doi-asserted-by":"crossref","unstructured":"Tonnhofer U, Balassy C, Reck CA, et al. Neuroendocrine tumor of the common hepatic duct, mimicking a choledochal cyst in a 6-year-old child. J Pediatr Surg 2009;44:E23-5. https:\/\/doi.org\/10.1016\/j.jpedsurg.2009.03.030","DOI":"10.1016\/j.jpedsurg.2009.03.030"},{"key":"10.32074\/1591-951X-231_ref6","doi-asserted-by":"crossref","unstructured":"Albores-Saavedra J, Nadji M, Henson DE, et al. Intestinal metaplasia of the gallbladder: a morphologic and immunocytochemical study. Hum Pathol 1986;17:614-20. https:\/\/doi.org\/10.1016\/s0046-8177(86)80134-4","DOI":"10.1016\/S0046-8177(86)80134-4"},{"key":"10.32074\/1591-951X-231_ref7","doi-asserted-by":"crossref","unstructured":"Eltawil KM, Gustafsson BI, Kidd M, et al. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol 2010;44:687-95. https:\/\/doi.org\/10.1097\/MCG.0b013e3181d7a6d4","DOI":"10.1097\/MCG.0b013e3181d7a6d4"},{"key":"10.32074\/1591-951X-231_ref8","doi-asserted-by":"crossref","unstructured":"Maitra A, Krueger JE, Tascilar M, et al. Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol 2000;24:1501-10. https:\/\/doi.org\/10.1097\/00000478-200011000-00005","DOI":"10.1097\/00000478-200011000-00005"},{"key":"10.32074\/1591-951X-231_ref9","doi-asserted-by":"crossref","unstructured":"Fellows IW, Leach IH, Smith PG, et al Carcinoid tumor of the common bile duct - a novel complication of von Hippel-Lindau syndrome. Gut 1990;31:728-9. https:\/\/doi.org\/10.1136\/gut.31.6.728","DOI":"10.1136\/gut.31.6.728"},{"key":"10.32074\/1591-951X-231_ref10","doi-asserted-by":"crossref","unstructured":"Nafidi O, Nguyen BN, Roy A. Carcinoid tumor of the common bile duct: a rare complication of von Hippel-Lindau syndrome. World J Gastroenterol 2008;14:1299-1301. https:\/\/doi.org\/10.3748\/wjg.14.1299","DOI":"10.3748\/wjg.14.1299"},{"key":"10.32074\/1591-951X-231_ref11","doi-asserted-by":"crossref","unstructured":"Lee SM, Sung CO. Neuroendocrine carcinomas of the gallbladder: a clinicopathologic and immunohistochemical analysis of 34 resected cases. Am J Surg Pathol 2020;44:1308-21. https:\/\/doi.org\/10.1097\/PAS.0000000000001536","DOI":"10.1097\/PAS.0000000000001536"},{"key":"10.32074\/1591-951X-231_ref12","doi-asserted-by":"crossref","unstructured":"Sciarra A, Missiaglia E, Trimech M, et al. Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) arising in intracholecystic papillary neoplasm: clinicopathologic and molecular analysis of a case and review of the literature. Endocr Pathol 2020;31:84-93. https:\/\/doi.org\/10.1007\/s12022-020-09605-6","DOI":"10.1007\/s12022-020-09605-6"},{"key":"10.32074\/1591-951X-231_ref13","doi-asserted-by":"crossref","unstructured":"Li M, Liu F, Zhang Y, et al. Whole-genome sequencing reveals the mutational landscape of metastatic small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC). Cancer Lett 2017;10;391:20-7. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.027","DOI":"10.1016\/j.canlet.2016.12.027"},{"key":"10.32074\/1591-951X-231_ref14","doi-asserted-by":"crossref","unstructured":"Kaino M, Kaino S, Goma W, et al. A case of mixed neuroendocrine non-neuroendocrine neoplasm of the distal bile duct with biliary intraepithelial neoplasia. Clin J Gastroenterol 2020 Jul 8. Epub ahead of print.","DOI":"10.1007\/s12328-020-01174-9"},{"key":"10.32074\/1591-951X-231_ref15","doi-asserted-by":"crossref","unstructured":"Zhang L, Yang Z, Chen Q, et al. Mixed adenoendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review. Oncol Lett 2019;18:1585-96. https:\/\/doi.org\/10.3892\/ol.2019.10502","DOI":"10.3892\/ol.2019.10502"},{"key":"10.32074\/1591-951X-231_ref16","doi-asserted-by":"crossref","unstructured":"Skalick\u00fd A, Vi\u0161tejnov\u00e1 L, Dubov\u00e1 M, et al. Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report. World J Surg Oncol 2019;22;17:55. https:\/\/doi.org\/10.1186\/s12957-019-1598-4","DOI":"10.1186\/s12957-019-1598-4"},{"key":"10.32074\/1591-951X-231_ref17","doi-asserted-by":"crossref","unstructured":"Zhang L, Wan D, Bao L, et al. Neuroendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review. Medicine (Baltimore) 2018;97:e11487. https:\/\/doi.org\/10.1097\/MD.0000000000011487","DOI":"10.1097\/MD.0000000000011487"},{"key":"10.32074\/1591-951X-231_ref18","doi-asserted-by":"crossref","unstructured":"La Rosa S, Sessa F, Uccella S. Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol 2016;27:284-311. https:\/\/doi.org\/10.1007\/s12022-016-9432-9","DOI":"10.1007\/s12022-016-9432-9"},{"key":"10.32074\/1591-951X-231_ref19","doi-asserted-by":"crossref","unstructured":"Uccella S, La Rosa S. Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology 2020;77:700-17. https:\/\/doi.org\/10.1111\/his.14178","DOI":"10.1111\/his.14178"},{"key":"10.32074\/1591-951X-231_ref20","doi-asserted-by":"crossref","unstructured":"Chu H, Zhang C, Shi Y, et al. Gallbladder neuroendocrine carcinoma:a single center experience. Medicine (Baltimore) 2020;99:e21912. https:\/\/doi.org\/10.1097\/MD.0000000000021912","DOI":"10.1097\/MD.0000000000021912"},{"key":"10.32074\/1591-951X-231_ref21","doi-asserted-by":"crossref","unstructured":"Liu W, Chen W, Chen J, et al. Neuroendocrine carcinoma of gallbladder: a case series and literature review. Eur J Med Res 2019;24:8. https:\/\/doi.org\/10.1186\/s40001-019-0363-z","DOI":"10.1186\/s40001-019-0363-z"},{"key":"10.32074\/1591-951X-231_ref22","doi-asserted-by":"crossref","unstructured":"Raiker R, Chauhan A, Hasanein H, et al. Biliary tract large cell neuroendocrine carcinoma: current evidence. Orphanet J Rare Dis 2019;14:266. https:\/\/doi.org\/10.1186\/s13023-019-1230-2","DOI":"10.1186\/s13023-019-1230-2"},{"key":"10.32074\/1591-951X-231_ref23","doi-asserted-by":"crossref","unstructured":"Uccella S, La Rosa S, Volante M, et al. Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol 2018;29:150-68. https:\/\/doi.org\/10.1007\/s12022-018-9522-y","DOI":"10.1007\/s12022-018-9522-y"},{"key":"10.32074\/1591-951X-231_ref24","unstructured":"Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of tumours of the digestive system. 5th ed. Lyon: IARC press 2019."},{"key":"10.32074\/1591-951X-231_ref25","doi-asserted-by":"crossref","unstructured":"Price TN, Thompson GB, Lewis JT, et al. Zollinger-Ellison syndrome due to primary gastrinoma of the extrahepatic biliary tree: three case reports and review of literature. Endocr Pract 2009;15:737-49.","DOI":"10.4158\/EP09022.RAR"},{"key":"10.32074\/1591-951X-231_ref26","doi-asserted-by":"crossref","unstructured":"Albores-Saavedra J, Batich K, Hossain S, et al. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Ann Diagn Pathol 2009;13:378-83. https:\/\/doi.org\/10.1016\/j.anndiagpath.2009.08.002","DOI":"10.1016\/j.anndiagpath.2009.08.002"},{"key":"10.32074\/1591-951X-231_ref27","doi-asserted-by":"crossref","unstructured":"Nomura Y, Nakashima O, Akiba J, et al. Clinicopathological features of neoplasms with neuroendocrine differentiation occurring in the liver. J Clin Pathol 2017;70:563-70. https:\/\/doi.org\/10.1136\/jclinpath-2016-203941","DOI":"10.1136\/jclinpath-2016-203941"},{"key":"10.32074\/1591-951X-231_ref28","doi-asserted-by":"crossref","unstructured":"Qiu MJ, Chen YB, Bi NR, et al. Comparative clinical analysis of gastroenteropancreatic neuroendocrine carcinomas with liver metastasis and primary hepatic neuroendocrine carcinomas. Dis Markers 2018;2018:9191639. https:\/\/doi.org\/10.1155\/2018\/9191639","DOI":"10.1155\/2018\/9191639"},{"key":"10.32074\/1591-951X-231_ref29","doi-asserted-by":"crossref","unstructured":"Shen YH, Chen S, Zhang WT, et al. Clinical analysis of gastroenteropancreatic neuroendocrine tumor with liver metastasis, compared with primary hepatic neuroendocrine tumor. J Cancer Res Ther 2014;10 Suppl:276-80. https:\/\/doi.org\/10.4103\/0973-1482.151532","DOI":"10.4103\/0973-1482.151532"},{"key":"10.32074\/1591-951X-231_ref30","doi-asserted-by":"crossref","unstructured":"Chen RW, Qiu MJ, Chen Y, et al. Analysis of the clinicopathological features and prognostic factors of primary hepatic neuroendocrine tumors. Oncol Lett 2018;15:8604-10. https:\/\/doi.org\/10.3892\/ol.2018.8413","DOI":"10.3892\/ol.2018.8413"},{"key":"10.32074\/1591-951X-231_ref31","doi-asserted-by":"crossref","unstructured":"Gravante G, De Liguori Carino N, Overton J, et al. Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg 2008;25:364-8. https:\/\/doi.org\/10.1159\/000167021","DOI":"10.1159\/000167021"},{"key":"10.32074\/1591-951X-231_ref32","doi-asserted-by":"crossref","unstructured":"Yu-Ping, X. & Ji-Yao, Y. Primary neuroendocrine carcinoma of the liver. Ultrastruct Pathol 1988;10:331-6. https:\/\/doi.org\/10.3109\/01913128609064197","DOI":"10.3109\/01913128609064197"},{"key":"10.32074\/1591-951X-231_ref33","unstructured":"Klimstra DS. Hepatic neuroendocrine neoplasms. In: WHO Classification of Tumors Editorial Board. Digestive system tumors. 5th ed. Vol 1. Lyon: IARC press 2019."},{"key":"10.32074\/1591-951X-231_ref34","doi-asserted-by":"crossref","unstructured":"Rasmussen J\u00d8, von Holstein SL, Prause JU, et al. Genetic analysis of an orbital metastasis from a primary hepatic neuroendocrine carcinoma. Oncol Rep 2014;32:1447-50.","DOI":"10.3892\/or.2014.3345"},{"key":"10.32074\/1591-951X-231_ref35","unstructured":"Shastri A, Msaouel P, Montagna C, et al. Primary hepatic small cell carcinoma: two case reports, molecular characterization and pooled analysis of known clinical data. Anticancer Res 2016;36:271-7."},{"key":"10.32074\/1591-951X-231_ref36","doi-asserted-by":"crossref","unstructured":"Pastri\u00e1n LG, Ruz-Caracuel I, Gonzalez RS. Giant primary neuroendocrine neoplasms of the liver: report of 2 cases with molecular characterization. Int J Surg Pathol 2019;27:893-9. https:\/\/doi.org\/10.1177\/1066896919855764","DOI":"10.1177\/1066896919855764"},{"key":"10.32074\/1591-951X-231_ref37","doi-asserted-by":"crossref","unstructured":"Zheng SL, Yip VS, Pedica F, et al. Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature. Diagn Pathol 2015;10:204. https:\/\/doi.org\/10.1186\/s13000-015-0439-1","DOI":"10.1186\/s13000-015-0439-1"},{"key":"10.32074\/1591-951X-231_ref38","doi-asserted-by":"crossref","unstructured":"Rascarachi G, Sierra M, Hernando M, et al. Primary liver carcinoid tumour with a Zollinger Ellison syndrome - an unusual diagnosis: a case report. Cases J 2009;2:6346. https:\/\/doi.org\/10.4076\/1757-1626-2-6346","DOI":"10.4076\/1757-1626-2-6346"},{"key":"10.32074\/1591-951X-231_ref39","doi-asserted-by":"crossref","unstructured":"Shah NA, Urusova IA, D\u2019Agnolo A, et al. Primary hepatic carcinoid tumor presenting as Cushing\u2019s syndrome. J Endocrinol Invest 2007;30:327-33. https:\/\/doi.org\/10.1007\/BF03346308","DOI":"10.1007\/BF03346308"},{"key":"10.32074\/1591-951X-231_ref40","doi-asserted-by":"crossref","unstructured":"Kwon HJ, Kim JW, Kim H, et al. Combined hepatocellular carcinoma and neuroendocrine carcinoma with ectopic secretion of parathyroid hormone: a case report and review of the literature. J Pathol Transl Med 2018;52:232-7. https:\/\/doi.org\/10.4132\/jptm.2018.05.17","DOI":"10.4132\/jptm.2018.05.17"},{"key":"10.32074\/1591-951X-231_ref41","doi-asserted-by":"crossref","unstructured":"Uccella S, Asa SL, Mete O. Metastatic neuroendocrine neoplasms of unknown primary site. In: Asa SL, La Rosa S, Mete O, eds. The spectrum of neuroendocrine neoplasia. Cham: Springer 2021. https:\/\/doi.org\/10.1007\/978-3-030-54391-4_16","DOI":"10.1007\/978-3-030-54391-4_16"},{"key":"10.32074\/1591-951X-231_ref42","doi-asserted-by":"crossref","unstructured":"Capurso G, Bettini R, Rinzivillo M, et al. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology 2011;93:223-9. https:\/\/doi.org\/10.1159\/000324770","DOI":"10.1159\/000324770"},{"key":"10.32074\/1591-951X-231_ref43","doi-asserted-by":"crossref","unstructured":"Venable ER, Kerr SE, Lopes MBS, et al. Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases. Diagn Pathol 2020;15:81. https:\/\/doi.org\/10.1186\/s13000-020-00997-x","DOI":"10.1186\/s13000-020-00997-x"},{"key":"10.32074\/1591-951X-231_ref44","doi-asserted-by":"crossref","unstructured":"Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 2007;20:1172-82. https:\/\/doi.org\/10.1038\/modpathol.3800954","DOI":"10.1038\/modpathol.3800954"},{"key":"10.32074\/1591-951X-231_ref45","doi-asserted-by":"crossref","unstructured":"Tang LH. Pancreatic neuroendocrine neoplasms: landscape and horizon. Arch Pathol Lab Med 2020 Apr 16. Online ahead of print. https:\/\/doi.org\/10.5858\/arpa.2019-0654-RA","DOI":"10.5858\/arpa.2019-0654-RA"},{"key":"10.32074\/1591-951X-231_ref46","doi-asserted-by":"crossref","unstructured":"Xue Y, Reid MD, Pehlivanoglu B, et al. Morphologic variants of pancreatic neuroendocrine tumors: clinicopathologic analysis and prognostic stratification. Endocr Pathol 2020;31:239-253. https:\/\/doi.org\/10.1007\/s12022-020-09628-z","DOI":"10.1007\/s12022-020-09628-z"},{"key":"10.32074\/1591-951X-231_ref47","doi-asserted-by":"crossref","unstructured":"Anlauf M, Wieben D, Perren A, et al. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol 2005;29:524-33. https:\/\/doi.org\/10.1097\/01.pas.0000151617.14598.ae","DOI":"10.1097\/01.pas.0000151617.14598.ae"},{"key":"10.32074\/1591-951X-231_ref48","doi-asserted-by":"crossref","unstructured":"Rosentraeger MJ, Garbrecht N, Anlauf M, et al. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior. Virchows Arch 2016;468:277-87. https:\/\/doi.org\/10.1007\/s00428-015-1890-9","DOI":"10.1007\/s00428-015-1890-9"},{"key":"10.32074\/1591-951X-231_ref49","doi-asserted-by":"crossref","unstructured":"Hamid QA, Bishop AE, Sikri KL, et al. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers. Histopathology 1986;10:119-33. https:\/\/doi.org\/10.1111\/j.1365-2559.1986.tb02468.x","DOI":"10.1111\/j.1365-2559.1986.tb02468.x"},{"key":"10.32074\/1591-951X-231_ref50","doi-asserted-by":"crossref","unstructured":"No\u00eb M, Pea A, Luchini C, et al. Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1. Mod Pathol 2018;31:1532-8. https:\/\/doi.org\/10.1038\/s41379-018-0082-y","DOI":"10.1038\/s41379-018-0082-y"},{"key":"10.32074\/1591-951X-231_ref51","doi-asserted-by":"crossref","unstructured":"McCall CM, Shi C, Klein AP, et al. Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Hum Pathol 2012;43:1169-76. https:\/\/doi.org\/10.1016\/j.humpath.2011.09.014","DOI":"10.1016\/j.humpath.2011.09.014"},{"key":"10.32074\/1591-951X-231_ref52","doi-asserted-by":"crossref","unstructured":"Yachida S, Vakiani E, White CM et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012;36:173-84. https:\/\/doi.org\/10.1097\/PAS.0b013e3182417d36","DOI":"10.1097\/PAS.0b013e3182417d36"},{"key":"10.32074\/1591-951X-231_ref53","doi-asserted-by":"crossref","unstructured":"Luchini C, Capelli P, Scarpa A. Pancreatic ductal adenocarcinoma and its variants. Surg Pathol Clin 2016;9:547-60. https:\/\/doi.org\/10.1016\/j.path.2016.05.003","DOI":"10.1016\/j.path.2016.05.003"},{"key":"10.32074\/1591-951X-231_ref54","doi-asserted-by":"crossref","unstructured":"Pelosi G, Zamboni G, Doglioni C, et al. Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 1992;16:1215-25. https:\/\/doi.org\/10.1097\/00000478-199212000-00008","DOI":"10.1097\/00000478-199212000-00008"},{"key":"10.32074\/1591-951X-231_ref55","doi-asserted-by":"crossref","unstructured":"Pelosi G, Bresaola E, Bogina G, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27:1124-34. https:\/\/doi.org\/10.1016\/s0046-8177(96)90303-2","DOI":"10.1016\/S0046-8177(96)90303-2"},{"key":"10.32074\/1591-951X-231_ref56","doi-asserted-by":"crossref","unstructured":"Agaimy A, Erlenbach-W\u00fcnsch K, Konukiewitz B, et al. ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol 2013;26:995-1003. https:\/\/doi.org\/10.1038\/modpathol.2013.40","DOI":"10.1038\/modpathol.2013.40"},{"key":"10.32074\/1591-951X-231_ref57","doi-asserted-by":"crossref","unstructured":"Uccella S, Sessa F, La Rosa S. Diagnostic approach to neuroendocrine neoplasms of the gastrointestinal tract and pancreas. Turk Patoloji Derg 2015;31 Suppl 1:113-27. https:\/\/doi.org\/10.5146\/tjpath.2015.01319. PMID: 26177322.","DOI":"10.5146\/tjpath.2015.01319"},{"key":"10.32074\/1591-951X-231_ref58","doi-asserted-by":"crossref","unstructured":"Scarpa A, Chang DK, Nones K, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 2017;543:65-71. https:\/\/doi.org\/10.1038\/nature21063","DOI":"10.1038\/nature21063"},{"key":"10.32074\/1591-951X-231_ref59","doi-asserted-by":"crossref","unstructured":"Marinoni I, Kurrer AS, Vassella E, et al. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 2014;146:453-460.e5. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.020","DOI":"10.1053\/j.gastro.2013.10.020"},{"key":"10.32074\/1591-951X-231_ref60","doi-asserted-by":"crossref","unstructured":"La Rosa S, Sessa F, Capella C. Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology. Front Med (Lausanne) 2015;2:41. https:\/\/doi.org\/10.3389\/fmed.2015.00041. PMID: 26137463; PMCID: PMC4469112.","DOI":"10.3389\/fmed.2015.00041"},{"key":"10.32074\/1591-951X-231_ref61","doi-asserted-by":"crossref","unstructured":"La Rosa S, Bongiovanni M. Pancreatic solid pseudopapillary neoplasm: key pathologic and genetic features. Arch Pathol Lab Med 2020 Jan 20. https:\/\/doi.org\/10.5858\/arpa.2019-0473-RA. Epub ahead of print. PMID: 31958381.","DOI":"10.5858\/arpa.2019-0473-RA"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:25:31Z","timestamp":1730813131000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-231","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"article-number":"5"}}